Which of the following Ovarian neoplasm shows Rokitansky’s protuberance:
**Question:** Which of the following Ovarian neoplasm shows Rokitansky's protuberance:
A. Ovarian cyst
B. Ovarian tumor
C. Ovarian cystadenoma
D. Ovarian teratoma
**Correct Answer:** D. Ovarian teratoma
**Core Concept:**
Rokitansky's protuberance refers to the presence of mature ectodermal, mesodermal, and endodermal derivatives within a teratoma. Teratomas are benign neoplasms that contain diverse cell types, derived from three germ cell layers: ectoderm, mesoderm, and endoderm. These derivatives can consist of hair, teeth, bone, cartilage, fat, muscle, and various organs.
**Why the Correct Answer is Right:**
Ovarian teratomas are the result of abnormal embryological development in which germ cells fail to undergo differentiation and form a teratoma. This results in the presence of different tissues within the tumor. Teratomas are classified as mature or immature based on the presence of tissue derivatives. Mature teratomas contain only differentiated tissues, while immature teratomas contain undifferentiated tissues. Rokitansky's protuberance is a characteristic feature of ovarian teratomas, making option D the correct answer.
**Why Each Wrong Option is Incorrect:**
A. Ovarian cyst: A cyst is a fluid-filled sac within the ovary, which is a normal physiological occurrence. Cysts may be benign or malignant, but they do not represent a specific type of ovarian neoplasm.
B. Ovarian tumor: A tumor is a generic term for any abnormal growth or mass of cells. It does not specify a particular type of ovarian neoplasm.
C. Ovarian cystadenoma: A cystadenoma is a benign tumor composed of glandular and serous cells. While it is a benign ovarian neoplasm, it does not include Rokitansky's protuberance, making it incorrect.
**Clinical Pearl:**
Rokitansky's protuberance is a valuable clinical feature that helps in differentiating between mature and immature teratomas. A mature teratoma may present with Rokitansky's protuberance, which is a bulging, tender mass in the pelvis, abdomen, or retroperitoneum. This feature is crucial in guiding clinical management decisions for these patients, such as monitoring the tumor's growth rate or considering surgery.